Qxp Pharma Project And Gmp Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Qxp Pharma Project And Gmp Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vaishali Sojitra, Pankajbhai Sojitra, Dineshkumar Prajapati, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24299GJ2022PTC129434
- Company No.
129434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Qxp Pharma Project And Gmp Services?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaishali Sojitra  | Director | 17-Feb-2022 | Current |
| Pankajbhai Sojitra | Director | 17-Feb-2022 | Current |
| Dineshkumar Prajapati | Director | 12-Jul-2022 | Current |
| Vijaybhai Patel | Director | 07-Apr-2023 | Current |
| Alokbhai Panchal | Director | 07-Apr-2023 | Current |
Financial Performance of Qxp Pharma Project And Gmp Services.
Qxp Pharma Project And Gmp Services Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Qxp Pharma Project And Gmp Services?
Unlock access to Qxp Pharma Project And Gmp Services's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pharmastra Lifecare Private LimitedActive 7 years 6 monthsVaishali Sojitra and Pankajbhai Sojitra are mutual person
Inmedicare Private LimitedActive 3 years 11 monthsVaishali Sojitra and Pankajbhai Sojitra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Qxp Pharma Project And Gmp Services?
Unlock and access historical data on people associated with Qxp Pharma Project And Gmp Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qxp Pharma Project And Gmp Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qxp Pharma Project And Gmp Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
